Jeff has considerable experience in drafting and prosecuting patent applications in the software, electrical and electronic fields, including the principal subject matter areas of power control systems, computer architectures, digital communications, flat panel displays, digital video coding, and test and measurement instruments. He has also had experience in drafting patent applications in the FinTech and Business Methods areas, primarily for filing in the US.
Jeff has managed extensive patent portfolios across the world, and so has gained significant non-European patent prosecution experience in countries including: USA; China; Japan; Australia; Canada; India; Taiwan; Indonesia; Malaysia. As such, Jeff provides a one-stop-shop for clients without any in house IP function.
Some of the more specific other subject matters Jeff has handled over the last 18 years of practice include: Standard Essential Patents in advanced digital communications (802.11xx WiFi and Cellular Standards, particularly 5G); computer security technology; encryption; biomedical sensors; flat panel displays (LCD/Plasma, inc 3D display); digital video compression; domestic appliances; navigation systems; semiconductor manufacturing techniques (planar and 3D); nanotubes; medical devices.
Jeff's established clients include SMEs in Computer Security/Software and MEMs based biomedical/industrial sensors, and global corporations in the computing, telecommunications and test and measurement equipment areas. As such, Jeff has managed patent portfolios for start-ups and Fortune 500 US corporations alike.
Overall Jeff is a technologically excellent and proactive advisor that helps clients to navigate their IP needs with a strong emphasis on the commercial reality of their businesses, whilst always mindful of the legal issues at hand.
University of Bristol, Electrical & Electronic Engineering
Queen Mary, University of London, IP Certificate
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.